Join our expert panel for discussions on:

  • Mechanisms of fibrosis in different organs and common pathways
  • Treatments for fibrosis in other organs systems
  • Assessment and clinical management of fibrostenotic disease in patients with IBD
  • Developing new imaging, biomarker, and clinical endpoints for drug development
  • Exploring the pipeline of drug development for fibrostenosis in IBD

Followed by a panel discussion and Q & A led by Iris Dotan, MD, Director, Division of Gastroenterology.
To View This Recording, Please Register Here: To learn more about our solutions, please visit Alimentiv.com

Thomas Wynn, PhD
Thomas Wynn, PhD

Pfizer, VP Discovery
Immunology and Inflammation

Full Bio
Julian Panes, MD
Julian Panes, MD

Director, IBD Unit
Hospital Clinic, Barcelona

Full Bio
Florian Rieder, MD
Florian Rieder, MD

Director, IBD Research
Cleveland Clinic Foundation, OH

Full Bio
Iris Dotan, MD
Iris Dotan, MD

Director, Division of Gastroenterology
Rabin Medical Center, Israel

Full Bio